Page last updated: 2024-10-25

cimetidine and B. burgdorferi Infection

cimetidine has been researched along with B. burgdorferi Infection in 1 studies

Cimetidine: A histamine congener, it competitively inhibits HISTAMINE binding to HISTAMINE H2 RECEPTORS. Cimetidine has a range of pharmacological actions. It inhibits GASTRIC ACID secretion, as well as PEPSIN and GASTRIN output.
cimetidine : A member of the class of guanidines that consists of guanidine carrying a methyl substituent at position 1, a cyano group at position 2 and a 2-{[(5-methyl-1H-imidazol-4-yl)methyl]sulfanyl}ethyl group at position 3. It is a H2-receptor antagonist that inhibits the production of acid in stomach.

Research Excerpts

ExcerptRelevanceReference
"Cimetidine (CIM) is an over-the-counter histamine-2 (H2) antagonist that is primarily used to lower acid secretions in the stomach."5.51Cimetidine as a novel adjunctive treatment for early stage Lyme disease. ( Shemenski, J, 2019)
"Cimetidine (CIM) is an over-the-counter histamine-2 (H2) antagonist that is primarily used to lower acid secretions in the stomach."1.51Cimetidine as a novel adjunctive treatment for early stage Lyme disease. ( Shemenski, J, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shemenski, J1

Other Studies

1 other study available for cimetidine and B. burgdorferi Infection

ArticleYear
Cimetidine as a novel adjunctive treatment for early stage Lyme disease.
    Medical hypotheses, 2019, Volume: 128

    Topics: Anti-Bacterial Agents; Autoimmunity; Borrelia burgdorferi; Cimetidine; Cytokines; Histamine H2 Antag

2019